Skip to main content
News

Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit That Simplifies and Accelerates PCR Analysis for Research – COVID-19 – Hospimedica.com

By October 12, 2020No Comments
QIAprep& Viral RNA UM Kit (Photo courtesy of QIAGEN N.V.)

QIAprep& Viral RNA UM Kit (Photo courtesy of QIAGEN N.V.)

QIAGEN N.V. (Venlo, Netherlands) plans to launch a novel straightforward approach to viral RNA epidemiology that will significantly simplify and accelerate PCR analysis and remove key testing bottlenecks for SARS-CoV-2 and other RNA viruses.

QIAGEN’s innovative QIAprep& Viral RNA UM Kit combines a liquid-based sample preparation step completed in only two minutes with real-time PCR detection in a streamlined workflow that can be automated with standard lab equipment for any throughput, any assay and any reaction need from single to multiplex testing. The kit, which uses the most common transport media such as Universal Transport Media (UTMTM) as the starting material, includes both sample extraction components and optimized PCR reagents for only one procedure.

Image: QIAprep& Viral RNA UM Kit (Photo courtesy of QIAGEN N.V.)

{iframe}https://www.hospimedica.com/covid-19/articles/294784859/qiagen-to-complement-covid-19-testing-portfolio-with-novel-kit-that-simplifies-and-accelerates-pcr-analysis-for-research.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.